The company
Regencell Bioscience Holdings Limited -
RGC · Nasdaq
RGC stood above a rising 150-day average in 27 of the last 52 weekly readings, and has been out of that trend for the last 21 weeks. It is 36.1% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 21
- Industry in uptrend
- 31% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 13
- Institutions holding
- 36 (+7)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 27 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
13 disclosed lines: House 11, Senate 2, executive 0; 4 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| James B. Renacci House: U.S. House ClerkOH16 | sold | $100k–$250k | 14 Feb 2018filed 21 Feb 2018 |
| Lois Frankel House: U.S. House ClerkFL21 | sold | $1k–$15k | 9 Jan 2018filed 23 Jan 2018 |
| Lois Frankel House: U.S. House ClerkFL21 | sold | $1k–$15k | 8 Jan 2018filed 23 Jan 2018 |
| Michael F. Bennet Senate: U.S. Senate eFDSenator | sold | $500k–$1M | 8 Dec 2017filed 21 Dec 2017 |
| Lois Frankel House: U.S. House ClerkFL21 | sold | $1k–$15k | 8 Dec 2017filed 20 Dec 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $15k–$50k | 1 Jun 2017filed 22 Jun 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 31 May 2017filed 7 Jun 2017 |
| Gary J. Palmer House: U.S. House ClerkAL06 | bought | $1k–$15k | 4 Apr 2017filed 29 Sep 2018 |
| Michael F. Bennet Senate: U.S. Senate eFDSenator | sold part of | $500k–$1M | 28 Mar 2017filed 10 Apr 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $15k–$50k | 31 Jan 2017filed 7 Feb 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $15k–$50k | 30 Jan 2017filed 7 Feb 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 26 Jan 2017filed 7 Feb 2017 |
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 422,011$2.6M | +6,442+1.6% |
| Alyeska Investment Group, L.P.new · filed 14 Aug 2026 | 416,261$2.5M | +416,261 |
| Legal & General Group Plcadded · filed 14 Aug 2026 | 128,000$779K | +118,097+1192.5% |
| JANE STREET GROUP, LLCnew · filed 14 Aug 2026 | 98,348$599K | +98,348 |
| XTX Topco Ltdnew · filed 14 Aug 2026 | 60,061$366K | +60,061 |
| Amundiadded · filed 11 Aug 2026 | 47,159$287K | +38,564+448.7% |
| UBS Group AGadded · filed 13 Aug 2026 | 43,208$263K | +19,323+80.9% |
| Quadrature Capital Ltdnew · filed 7 Aug 2026 | 41,750$254K | +41,750 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 2026 | 23,129$141K | +23,129 |
| Squarepoint Ops LLCreduced · filed 14 Aug 2026 | 22,036$134K | -4,577−17.2% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.